|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2001-9-10
|
|
pubmed:abstractText |
Although soluble CD44 (sCD44) is considered a reliable marker of both tumor burden and disease activity, to the authors' knowledge, its predictive and prognostic value in B-cell chronic lymphocytic leukemia (CLL) has not been addressed to date.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2001 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
92
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
713-9
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11550139-Adult,
pubmed-meshheading:11550139-Aged,
pubmed-meshheading:11550139-Aged, 80 and over,
pubmed-meshheading:11550139-Antigens, CD44,
pubmed-meshheading:11550139-Biological Markers,
pubmed-meshheading:11550139-Disease Progression,
pubmed-meshheading:11550139-Female,
pubmed-meshheading:11550139-Humans,
pubmed-meshheading:11550139-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:11550139-Male,
pubmed-meshheading:11550139-Middle Aged,
pubmed-meshheading:11550139-Prognosis,
pubmed-meshheading:11550139-Regression Analysis,
pubmed-meshheading:11550139-Survival Analysis
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression.
|
|
pubmed:affiliation |
Divisione Ematologia e Oncologia Clinica, Azienda Ospedaliera Pugliese-Ciaccio, via Pio X, 88100 Catanzaro, Italy. smolica@libero.it
|
|
pubmed:publicationType |
Journal Article
|
